Ilan Levin
CIK: 0001849189
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLXN
Silexion Therapeutics Corp
Director10% Owner
Discretionary Trading P&L
Holdings
About Levin Ilan
Levin Ilan (SEC CIK 0001849189) files insider reports with the SEC as Director of Silexion Therapeutics Corp (SLXN).
Signal8 holds 1 ownership filing by Levin Ilan, a Form 4, filed on Jan 27, 2026. Those filings report 2 transactions, from Aug 7, 2025 to Sep 15, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Levin Ilan's filings is in RAMAT GAN, L3.
Recent filings by Levin Ilan
Other insiders filing for Silexion Therapeutics Corp (SLXN)
- Shirvan Mitchell, CSO and CDO
- Horenshtein Hadar Mirit, CFO and Secretary
- Hadar Ilan, Chairman and CEO
- Noy Shlomo, Director
- Alon Ruth, Director
- Abramov Dror Yosef, Director